AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023

In-depth characterization of CD3-binding antibodies reveals molecules with binding and functional properties that are differentiated from antibodies commonly used for T-cell engager... | April 17, 2023

Related Keywords

Orlando ,Florida ,United States ,Orange County Convention Center ,American ,Murray Mccutcheon ,Bo Barnhart ,Abcellera Biologics Inc ,Translational Research At Abcellera ,American Society For Cancer Research ,Exchange Commission ,American Society ,Cancer Research ,Annual Meeting ,Translational Research ,Private Securities Litigation Reform Act ,Financial Condition ,Abcellera Biologics Inc Stock Exchange ,News ,Information ,Press Release ,Characterization ,F ,Antibodies ,Eveals ,Molecules ,Ith ,Finding ,End ,Unctional ,Properties ,Hat ,Fire ,Differentiated ,Rom ,Commonly ,Ased ,Or Abcl Ca00288u1066 ,